Frédérick Antoine-Mallette

14PUBLICATIONS
93CO-AUTHORS
Molecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 26, 2025
Inhibition of MCL-1 to eliminate senescent cells and mitigate renal fibrosis in aristolochic acid nephropathy.

Peng Gao, Schrodinger Cenatus, Nathalie Henley

|Jul 02, 2025
O-GlcNAcylation of FOXK1 co-opts BAP1 to orchestrate the E2F pathway and promotes oncogenesis.

Oumaima Ahmed, Louis Masclef, Nicholas Iannantuono

|Jun 11, 2025
R-2-hydroxyglutarate-mediated inhibition of KDM4A compromises telomere integrity.

Florence Couteau, Laurence M Gagné, Karine Boulay

|Mar 11, 2024
O-GlcNAcylation of FOXK1 orchestrates the E2F pathway and promotes oncogenesis.

Louis Masclef, Oumaima Ahmed, Nicholas Iannantuono

|Aug 09, 2023
FIRRM cooperates with FIGNL1 to promote RAD51 disassembly during DNA repair.

Edgar Pinedo-Carpio, Julien Dessapt, Adèle Beneyton

|Feb 01, 2023
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.

Sathyen A Prabhu, Omar Moussa, Christophe Gonçalves

Pageof 3